G Medical Innovations Holdings Ltd. (GMVD)
G Medical Innovations is an early commercial stage healthcare company engaged in the development of next generation mobile health (or mHealth) and telemedicine solutions and monitoring service platforms.
We believe we are at the forefront of the digital health revolution in developing the next generation mobile technologies and services that are designed to empower consumers, patients and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease and diabetes.
Using our proprietary and patented suite of devices, software solutions, algorithms and monitoring services, we intend to drive recurring revenue streams in two vertical markets, with a focus on markets in the United States and China as well as other markets: Business to business (or B2B): professional healthcare markets (including hospitals, clinics and senior care facilities); and Business to business to consumer (or B2B2C) and business to consumer (or B2C): consumer healthcare markets.
|IPO Date||Jun 25, 2021|
|Industry||Medical Instruments & Supplies|
|Fiscal Year||January - December|
|Reporting Currency||US Dollars|